In a Historic First, Quality Assured Cannabis Is Now Available to Hawai`i’s Patients
AUGUST 8, 2017 – Hawaiʻi’s first medical cannabis dispensary is officially open for business. Today Maui Grown Therapies will transact the state’s first legal sale of medical cannabis, a historic milestone for the Aloha State.
One year and three months ago Maui Grown Therapies earned the state’s first medical cannabis dispensary license after achieving a near perfect score of 510 of a possible 520 points in a merit based evaluation process conducted by the Hawaiʻi Department of Health (DOH). In February, the company received the state’s first Notice to Proceed with Cultivation and today, the company got the first green light to sell after its final onsite retail inspection by the DOH yesterday morning.
“It’s been a long, winding road to get here and we’re extremely excited,” said cofounder Gregory Park, MD. “We want to thank State Senator Roz Baker and Representative Della Bellati for their leadership and the Department of Health for establishing high compliance standards for this emerging industry. Getting to this day required hard work, cooperation and patience, but it’s worth it to be able to bring this alternative therapy to our Maui community.”
Maui Grown Therapies will ease into operations with a short “soft opening week” during which patients who have gone through pre-opening intake will be able to purchase by appointment. On Monday, August 14, walk-in business and regular operating hours (Mon-Sat, 10 am to 7 pm) will commence at the company’s dispensary at 44 Paʻa Street in the Maui Lani Village Center in Kahului.
There is no charge to patients who want to meet with the company’s Patient Education Specialists to learn how medical cannabis can help manage their symptoms and which cannabis cultivars or derivative products are best suited for their condition and lifestyle. Cannabis researcher and author of Cannabis Pharmacy, Michael Backes, developed the curriculum and personally trained MGT’s employees during the company’s intensive academy in July.
Backes is a member of Maui Grown Therapies’ Science & Medical Advisory Board led by Chief Science Officer Andrew Weil, MD. Comprised of physicians, researchers, and agriculturists, the board meets regularly to share the latest research and information about medicinal cannabis and advises Maui Grown Therapies on product mix and specific formulations for Hawaiʻi’s qualifying conditions. Other SMA members include Donald Abrams, MD; Brian Becker, MD; Julie Holland, MD; Gregory Park, MD; Greg Yim, MD; and Dr. Jeff McElroy.
Maui Grown Therapies will open with a selection of dried cannabis flower. The company planned to open with a selection of derivative products such as oils, lotions, concentrates and tinctures, but the Department of Health has not yet certified a lab to test manufactured cannabis products.
Maui Grown Therapies is a green company in more ways than one. Its Upcountry production center is powered by a solar microgrid featuring a full array of photovoltaic panels and lithium ion battery storage banks capable of storing 1 MW of electricity. MGT also reuses its irrigation water by recapturing and filtering atmospheric condensate in its climate control system.